Cambridge Investment Research Advisors’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,383
Closed -$201K 3530
2024
Q2
$201K Sell
4,383
-121
-3% -$5.71K ﹤0.01% 3036
2024
Q1
$234K Sell
4,504
-5,670
-56% -$249K ﹤0.01% 2892
2023
Q4
$362K Sell
10,174
-9,168
-47% -$319K ﹤0.01% 2457
2023
Q3
$648K Sell
19,342
-625
-3% -$21.7K ﹤0.01% 1880
2023
Q2
$750K Sell
19,967
-1,350
-6% -$44.4K ﹤0.01% 1822
2023
Q1
$625K Buy
21,317
+118
+0.6% +$3.42K ﹤0.01% 1934
2022
Q4
$558K Sell
21,199
-353
-2% -$8.4K ﹤0.01% 1927
2022
Q3
$500K Sell
21,552
-194
-0.9% -$5.29K ﹤0.01% 1938
2022
Q2
$548K Sell
21,746
-536
-2% -$15.8K ﹤0.01% 1898
2022
Q1
$852K Sell
22,282
-377
-2% -$13.6K ﹤0.01% 1684
2021
Q4
$890K Buy
22,659
+705
+3% +$30.9K ﹤0.01% 1658
2021
Q3
$1.07M Buy
21,954
+697
+3% +$36.1K 0.01% 1461
2021
Q2
$1.12M Sell
21,257
-171
-0.8% -$9.74K 0.01% 1461
2021
Q1
$1.19M Buy
21,428
+415
+2% +$18.8K 0.01% 1314
2020
Q4
$649K Buy
21,013
+60
+0.3% +$1.43K ﹤0.01% 1595
2020
Q3
$388K Sell
20,953
-5,100
-20% -$84.4K ﹤0.01% 1771
2020
Q2
$360K Sell
26,053
-125
-0.5% -$1.69K ﹤0.01% 1749
2020
Q1
$240K Buy
26,178
+4,068
+18% +$61K ﹤0.01% 1819
2019
Q4
$385K Buy
22,110
+2,621
+13% +$44.6K ﹤0.01% 1755
2019
Q3
$295K Buy
19,489
+2,974
+18% +$52K ﹤0.01% 1835
2019
Q2
$312K Buy
16,515
+5,651
+52% +$96.4K ﹤0.01% 1725
2019
Q1
$190K Buy
+10,864
New +$199K ﹤0.01% 2083

Other funds holding VCEL

Cambridge Investment Research Advisors's VCEL Position: Q3 2024 in Review

Cambridge Investment Research Advisors sold out of Vericel Corp (VCEL) in Q3 2024, closing a stake of 4,383 shares — an estimated $201K sold.

Cambridge Investment Research Advisors first reported a position in VCEL in Q1 2019 and held it in 22 quarters. The position peaked at $1.19M in Q1 2021. 268 funds tracked by Wall St. Rank hold VCEL as of Q3 2024.

  • Cambridge Investment Research Advisors reported no remaining Vericel Corp position as of Q3 2024 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 4,383 Vericel Corp shares in Q3 2024, an estimated $201K.
  • Cambridge Investment Research Advisors first reported a position in Vericel Corp in Q1 2019 and held it in 22 quarters.
  • Cambridge Investment Research Advisors's Vericel Corp position peaked at $1.19M in Q1 2021.
  • 268 funds tracked by Wall St. Rank held Vericel Corp as of Q3 2024.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2024, filed 28 Oct 2024.